Forgot your password?
Haven't registered yet?
7 hours agoExperimental PfSPZ malaria vaccine provides durable protection against multiple strains in NIH clini
23 hours agoNews Scan for Feb 20, 2017
23 hours agoVietnam reports H5N6 and H5N1 outbreaks as Europe battles more H5N8
6/22/2017 » 6/25/20172017 OSAP Annual Conference
Pfizer Inc said on Tuesday the U.S. Food and Drug Administration had expanded the use of its best-selling pneumonia vaccine, Prevnar, to adults aged 18 through 49.
The vaccine, which is already approved for use in adults aged 50 and above, and children aged 6 weeks to 17 years, prevents invasive diseases caused by 13 Streptococcus pneumoniae strains.
OSAP Disclaimer | Please notify our webmaster of any problems with this website.
OSAP thanks its Super Sponsors for their support in 2016. Sponsorship does not imply endorsement by OSAP of a company's products or services.